ArticlePloS one2026
A two-phase core-plasma model for microvascular blood flow: Comparative analysis of hemodynamic models.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microcirculatory blood flow exhibits complex non-Newtonian behavior, including shear-thinning properties and the formation of a cell-free layer (CFL)-a plasma-rich region near vessel walls. While traditional rheological models such as Newtonian, Power Law, and Carreau describe certain flow characteristics, and empirical models like the double-parameter power fit have been used to capture velocity profiles, these approaches fall short in fully characterizing the dynamic interplay between red blood cells (RBCs) and plasma. This study introduces the Core-Plasma Model, a two-phase framework that integrates Newtonian and non-Newtonian elements to represent the RBC-rich core and surrounding CFL. In vitro experiments in 25 [Formula: see text]m and 50 [Formula: see text]m round channels across varying flow rates, hematocrit levels (5-20%), and suspending media (PBS and native plasma) demonstrate the model's superior ability to capture velocity and shear rate profiles. The Core-Plasma Model offers a robust platform for advancing microscale hemodynamic predictions and deepening the understanding of microvascular flow dynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.